ReviewCureus2026

Oral Small-Molecule Therapies Versus Biologic Agents in Moderate-to-Severe Ulcerative Colitis: A Systematic Review of Pivotal Phase 3 Trials.

Okasha Zulfiqar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.